Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaneck Biotech ETF (NQ: BBH )

149.08 +3.29 (+2.26%)
Official Closing Price Updated: 4:15 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,088
Open 145.85
Bid (Size) 147.75 (10)
Ask (Size) 151.85 (10)
Prev. Close 145.79
Today's Range 145.64 - 149.15
52wk Range 131.12 - 222.22
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
Progenity Is Unlikely to Live Up to Its IPO Hype
Progenity went public in June 2020. Eighteen months later, PROG stock has lost 83% of its value. Is there any hope for this fading biotech? 
Via InvestorPlace

Performance

YTD
-20.06%
-20.06%
1 Month
+1.55%
+1.55%
3 Month
-10.91%
-10.91%
6 Month
-20.06%
-20.06%
1 Year
-26.56%
-26.56%

More News

Read More
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
Via Talk Markets
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
Via InvestorPlace
Take A Look At The Top-Performing Biotech ETFs YTD
Via Talk Markets
Exposures COVID-19
Biotech ETFs To Benefit From Latest Booster Update
Via Talk Markets
Exposures COVID-19
ETF Investing Areas to Consider for August
Via Talk Markets
Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
Via Talk Markets
Exposures COVID-19
5 Top ETFs With Exposure To Biogen
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Benzinga
Exposures Product Safety
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
Via Talk Markets
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.